FTC Sues Hims & Hers Health, Top Pharma Stocks to Watch

The Federal Trade Commission (FTC) is suing Hims & Hers Health for allegedly making false and unsubstantiated claims about their products. Despite this, investors are advised not to panic as the company's growth prospects remain intact.

MarketBeat has identified seven pharmaceutical stocks that investors should watch closely: Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Pfizer (PFE), and AstraZeneca PLC (AZN).

These companies are leaders in their respective fields, with a strong pipeline of new products and technologies that have the potential to drive growth.